Insider · CIK 0001965920
Christiane Pendarvis
director
Files at HIMS (Hims & Hers Health, Inc.). First filing Mar 6, 2025, latest Mar 6, 2025.
Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
0 / 1
$0 bought, $500k sold
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
HIMS: Hims & Hers Health, Inc.
HIMSOct 9, 2026 · close 30.92
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 68Notable | Hims & Hers Health, Inc. | $500k 12,500 shares | -52% | +168% from low-41% from high |
Transactions
Every row this insider has filed, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Aug 6, 2025 | HIMS Hims & Hers Health, Inc. | AGrant or award Restricted Stock Unitderivative | +3,656 | $0.00 | $0 | 3,656 | Aug 8, 2025 |
| Jun 12, 2025 | HIMS Hims & Hers Health, Inc. | MOption exercise Class A Common Stock | +9,935 | - | - | 36,563 | Jun 16, 2025 |
| Jun 12, 2025 | HIMS Hims & Hers Health, Inc. | MOption exercise Restricted Stock Unitderivative | -9,935 | $0.00 | $0 | 0 | Jun 16, 2025 |
| Mar 14, 2025 | HIMS Hims & Hers Health, Inc. | MOption exercise Class A Common Stock | +15,211 | - | - | 26,628 | Mar 18, 2025 |
| Mar 14, 2025 | HIMS Hims & Hers Health, Inc. | MOption exercise Restricted Stock Unitderivative | -15,211 | $0.00 | $0 | 15,211 | Mar 18, 2025 |
| Mar 5, 2025 | HIMS Hims & Hers Health, Inc. | SOpen-market sale Class A Common Stock | -12,500 | $40.00 | $500k | 11,417 | Mar 6, 2025 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.